Maria Theresa Alera

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 225 citations · Full text

Veterinary Medicine, Child Health, Infectious Diseases +17

High Rate of Subclinical Chikungunya Virus Infection and Association of Neutralizing Antibody with Protection in a Prospective Cohort in The Philippines

In‐Kyu Yoon, Maria Theresa Alera, Catherine B. Lago et al. · PLoS neglected tropical diseases · 2015 · 172 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections

Mariko Saito, Kazunori Oishi, Satoshi Inoue et al. · Clinical & Experimental Immunology · 2004 · 134 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Reconstruction of 60 Years of Chikungunya Epidemiology in the Philippines Demonstrates Episodic and Focal Transmission

Henrik Salje, Simon Cauchemez, Maria Theresa Alera et al. · The Journal of Infectious Diseases · 2015 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

Eduardo López‐Medina, Shibadas Biswal, Xavier Sáez‐Llorens et al. · The Journal of Infectious Diseases · 2020 · 106 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17